美媒：腾讯参投林俊旸AI公司2000万美元
Quick Answer
Tencent has invested $20 million in Lin Junyang's AI startup during its first funding round, which has raised hundreds of millions in total and is valued at around $2 billion.
Quick Take
Tencent has invested $20 million in Lin Junyang's AI startup during its first funding round, which has raised hundreds of millions in total and is valued at around $2 billion. The round was led by Gaorong Capital and Sequoia China, each contributing $100 million, as Lin seeks additional funding.
Key Points
- Tencent's investment marks a significant backing for Lin Junyang's AI lab.
- The AI lab has raised hundreds of millions, achieving a post-money valuation of $2 billion.
- Gaorong Capital and Sequoia China led this funding round with $100 million each.
- Lin Junyang is actively seeking additional funding after this successful round.
📖 Reader Mode
~1 min read雷峰网获悉，据The Information最新独家报道，腾讯在林俊旸创立的新人工智能实验室的第一轮融资中投资了2000万美元。
目前，该人工智能实验室已筹集了数亿美元，投后估值约为20亿美元。
雷峰网(公众号：雷峰网)得知，知情人士表示这一轮融资由高榕资本与红杉中国领导，各投资1亿美元。完成交易后，林俊旸已经在寻求再筹集一轮资金。
雷峰网原创文章，未经授权禁止转载。详情见转载须知。
— Originally published at leiphone.com
Want this in your inbox every morning?
Daily brief at your local 8am — bilingual EN/中文, free.
More from 雷峰网 AI
See more →
从诺奖项目到生成式药物设计，Latent Labs 创始人 Simon Kohl：AI 正在让生物学进入「可编程时代」 | CVPR 2026
Simon Kohl, CEO of Latent Labs, presented at CVPR 2026, highlighting how generative AI, including models like Latent-X1 and Latent-Y, is revolutionizing drug design by drastically reducing development times and costs, achieving up to 90% success rates compared to traditional methods. The transition from AlphaFold 2's structural predictions to autonomous design agents marks a pivotal shift towards programmable biology.
